Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment
J Bienvenu, R Chvetzoff, G Salles, et al.
Bone Marrow Transplantation
|
March 1, 2005
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia
A de Labarthe, C Pautas, X Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
Leukemia
|
July 1, 1996
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus
M J Dyer, D M Lillington, C Bastard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
T E Witzig, J M Vose, P L Zinzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
L de Leval, C Bonnet, C Copie-Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Céligny, P Brice, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment
J Bienvenu, R Chvetzoff, G Salles, et al.
Bone Marrow Transplantation
|
March 1, 2005
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia
A de Labarthe, C Pautas, X Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
Leukemia
|
July 1, 1996
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus
M J Dyer, D M Lillington, C Bastard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
T E Witzig, J M Vose, P L Zinzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
L de Leval, C Bonnet, C Copie-Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Céligny, P Brice, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
Page
of 16